Log In
BCIQ
Print this Print this
 

ONX 0801 (formerly BGC 945)

  Manage Alerts
Collapse Summary General Information
Company BTG plc
DescriptionThymidylate synthetase (TYMS) inhibitor selective for cells expressing the folate receptor 1 (FOLR1; FR-alpha)
Molecular Target Thymidylate synthetase (TYMS)
Mechanism of ActionThymidylate synthase inhibitor
Therapeutic Modality 
Latest Stage of DevelopmentPhase I
Standard IndicationSolid tumors
Indication DetailsTreat advanced solid tumors
Regulatory Designation
PartnerAmgen Inc.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today